Literature DB >> 24984993

Modulation of adipose tissue inflammation by FOXP3+ Treg cells, IL-10, and TGF-β in metabolically healthy class III obese individuals.

Solange Pereira1, Lílian Teixeira2, Edenil Aguilar2, Marina Oliveira3, Alexandre Savassi-Rocha4, Juliana Navia Pelaez5, Luciano Capettini5, Marco Túlio Diniz4, Adaliene Ferreira3, Jacqueline Alvarez-Leite6.   

Abstract

OBJECTIVE: The objective of this study was to compare the profiles of proinflammatory (interleukin [IL]-6 and tumor necrosis factor [TNF]) and anti-inflammatory (IL-10 and transforming growth factor [TGF]-β) adipokines in the blood, subcutaneous adipose tissue (SAT), and visceral adipose tissue (VAT) of metabolically healthy class III obese individuals and normal-weight controls.
METHODS: The serum concentrations (enzyme-linked immunosorbent assay [ELISA]), mRNA expression levels (reverse transcriptase polymerase chain reaction), and adipose tissue secretion (ELISA) of IL-6, TNF, IL-10, and TGF-β were analyzed, as were the mRNA expression of FOXP3 (present in regulatory T cells) and the secretion (Western blotting) of matrix metalloproteinases in the adipose tissue.
RESULTS: There were no differences in the circulating levels, expression, or secretion of IL-6 and TNF between the groups or tissues. The expression and circulating levels of IL-10 were higher in obese individuals, especially in the SAT. Although the blood concentration of TGF-β was similar between the groups, its expression and secretion levels were higher in the adipose tissues of obese individuals compared with controls. FOXP3 and MMP expression levels were higher in the SAT and VAT of obese individuals, respectively, compared with the controls.
CONCLUSION: Metabolically healthy, extremely obese individuals have effective immunoregulation to counter chronic obesity-related inflammation through the increased production of the anti-inflammatory cytokines IL-10 and TGF-β in adipose tissue, especially SAT; the increased presence of FOXP3-positive regulatory T cells; and increases in angiogenesis and adipogenesis induced by TGF-β and MMPs. These regulatory mechanisms could be important in the delayed onset of metabolic complications, even in extremely obese individuals.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adipokines; Adipose tissue; Inflammation; Obesity

Mesh:

Substances:

Year:  2013        PMID: 24984993     DOI: 10.1016/j.nut.2013.11.023

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  25 in total

Review 1.  T Cell Populations and Functions Are Altered in Human Obesity and Type 2 Diabetes.

Authors:  Sothea Touch; Karine Clément; Sébastien André
Journal:  Curr Diab Rep       Date:  2017-09       Impact factor: 4.810

Review 2.  Role of innate and adaptive immunity in obesity-associated metabolic disease.

Authors:  Tracey McLaughlin; Shelley E Ackerman; Lei Shen; Edgar Engleman
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

3.  IL-10 and TGF-β unbalanced levels in neutrophils contribute to increase inflammatory cytokine expression in childhood obesity.

Authors:  Nayara I Medeiros; Rafael T Mattos; Carlos A Menezes; Rafaelle C G Fares; André Talvani; Walderez O Dutra; Fabrício Rios-Santos; Rodrigo Correa-Oliveira; Juliana A S Gomes
Journal:  Eur J Nutr       Date:  2017-07-22       Impact factor: 5.614

4.  Low-Grade Inflammation, Obesity, and Diabetes.

Authors:  Solange S Pereira; Jacqueline I Alvarez-Leite
Journal:  Curr Obes Rep       Date:  2014-12

5.  RELATIONSHIP BETWEEN SELENIUM NUTRITIONAL STATUS AND MARKERS OF LOW-GRADE CHRONIC INFLAMMATION IN OBESE WOMEN.

Authors:  Larissa Cristina Fontenelle; Mickael de Paiva Sousa; Loanne Rocha Dos Santos; Bruna Emanuele Pereira Cardoso; Thayanne Gabryelle Visgueira de Sousa; Tamires da Cunha Soares; Stéfany Rodrigues de Sousa Melo; Jennifer Beatriz Silva Morais; Thaline Milany da Silva Dias; Francisco Erasmo de Oliveira; Débora Cavalcante Braz; João Marcelo de Castro E Sousa; Francisco Leonardo Torres-Leal; Gilberto Simeone Henriques; Dilina do Nascimento Marreiro
Journal:  Biol Trace Elem Res       Date:  2022-04-06       Impact factor: 3.738

6.  Transforming growth factor beta 1 (TGFβ1) plasmatic levels and haplotype structures in obesity: a role for TGFβ1 in steatosis development.

Authors:  Ingrid Felicidade; Mayara Bocchi; Marília Rizzon Zaparolli Ramos; Ligia de Oliveira Carlos; Nathalia Ramori Farinha Wagner; Antônio Carlos Ligocki Campos; Lúcia Regina Ribeiro; Mário Sérgio Mantovani; Maria Angelica Ehara Watanabe; Glauco Akelinghton Freire Vitiello
Journal:  Mol Biol Rep       Date:  2021-08-17       Impact factor: 2.316

7.  Increased levels of pathogenic Th17 cells and diminished function of CD69+ Treg lymphocytes in patients with overweight.

Authors:  Alejandra Mendoza-Pérez; Marlen Vitales-Noyola; Larisa González-Baranda; Crisol Álvarez-Quiroga; Berenice Hernández-Castro; Adriana Monsiváis-Urenda; Lourdes Baranda; Perla Niño-Moreno; Gilberto Hurtado; Raquel Sánchez-Gutiérrez; Roberto González-Amaro
Journal:  Clin Exp Immunol       Date:  2022-07-22       Impact factor: 5.732

Review 8.  The role of lipid metabolism in shaping the expansion and the function of regulatory T cells.

Authors:  Alessandra Pinzon Grimaldos; Simone Bini; Ilenia Pacella; Alessandra Rossi; Alessia Di Costanzo; Ilenia Minicocci; Laura D'Erasmo; Marcello Arca; Silvia Piconese
Journal:  Clin Exp Immunol       Date:  2022-06-11       Impact factor: 5.732

9.  Lower omental t-regulatory cell count is associated with higher fasting glucose and lower β-cell function in adults with obesity.

Authors:  Lauren E Gyllenhammer; Jonathan Lam; Tanya L Alderete; Hooman Allayee; Omid Akbari; Namir Katkhouda; Michael I Goran
Journal:  Obesity (Silver Spring)       Date:  2016-05-02       Impact factor: 5.002

10.  Foxp3 drives oxidative phosphorylation and protection from lipotoxicity.

Authors:  Duncan Howie; Stephen Paul Cobbold; Elizabeth Adams; Annemieke Ten Bokum; Andra Stefania Necula; Wei Zhang; Honglei Huang; David J Roberts; Benjamin Thomas; Svenja S Hester; David J Vaux; Alexander G Betz; Herman Waldmann
Journal:  JCI Insight       Date:  2017-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.